180 related articles for article (PubMed ID: 3054625)
1. A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.
Davies L; Wolska B; Hilbich C; Multhaup G; Martins R; Simms G; Beyreuther K; Masters CL
Neurology; 1988 Nov; 38(11):1688-93. PubMed ID: 3054625
[TBL] [Abstract][Full Text] [Related]
2. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
Ikeda S; Allsop D; Glenner GG
Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
[TBL] [Abstract][Full Text] [Related]
3. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.
Ikeda S; Allsop D; Glenner GG
Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985
[TBL] [Abstract][Full Text] [Related]
4. beta-Amyloid protein immunoreactivity in skin is not a reliable marker of Alzheimer's disease. An autopsy-controlled study.
Heinonen O; Soininen H; Syrjänen S; Neittaanmäki H; Paljärvi L; Kosunen O; Syrjänen K; Riekkinen P
Arch Neurol; 1994 Aug; 51(8):799-804. PubMed ID: 8042928
[TBL] [Abstract][Full Text] [Related]
5. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
[TBL] [Abstract][Full Text] [Related]
6. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.
Armstrong RA
Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269
[TBL] [Abstract][Full Text] [Related]
7. beta-Amyloid protein is higher in Alzheimer's disease brains: description of a quantitative biochemical assay.
Frucht SJ; Koo EH
J Neuropathol Exp Neurol; 1993 Nov; 52(6):640-7. PubMed ID: 8229083
[TBL] [Abstract][Full Text] [Related]
8. Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy.
Baker HF; Ridley RM; Duchen LW; Crow TJ; Bruton CJ
Mol Neurobiol; 1994 Feb; 8(1):25-39. PubMed ID: 8086126
[TBL] [Abstract][Full Text] [Related]
9. [Pathomorphological and amyloid beta-protein immunohistochemical findings in autopsied brains of Alzheimer's disease].
Liu D; Hk N; Man K; Luo X; Yang L; Sun Z
Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):405-8. PubMed ID: 11869551
[TBL] [Abstract][Full Text] [Related]
10. A demonstration of the advantages of immunostaining in the quantification of amyloid plaque deposits.
Gentleman SM; Bruton C; Allsop D; Lewis SJ; Polak JM; Roberts GW
Histochemistry; 1989; 92(4):355-8. PubMed ID: 2478507
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease.
Vinters HV; Nishimura GS; Secor DL; Pardridge WM
Am J Pathol; 1990 Aug; 137(2):233-40. PubMed ID: 2201197
[TBL] [Abstract][Full Text] [Related]
12. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
13. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.
Maggio JE; Stimson ER; Ghilardi JR; Allen CJ; Dahl CE; Whitcomb DC; Vigna SR; Vinters HV; Labenski ME; Mantyh PW
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5462-6. PubMed ID: 1608956
[TBL] [Abstract][Full Text] [Related]
14. Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer's disease.
Michael R; Rosandić J; Montenegro GA; Lobato E; Tresserra F; Barraquer RI; Vrensen GF
Exp Eye Res; 2013 Jan; 106():5-13. PubMed ID: 23142516
[TBL] [Abstract][Full Text] [Related]
15. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.
Masliah E; Iwai A; Mallory M; Uéda K; Saitoh T
Am J Pathol; 1996 Jan; 148(1):201-10. PubMed ID: 8546207
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical colocalization of amyloid precursor protein with cerebrovascular amyloid of Alzheimer's disease.
Ko LW; Sheu KF; Blass JP
Am J Pathol; 1991 Sep; 139(3):523-33. PubMed ID: 1716044
[TBL] [Abstract][Full Text] [Related]
17. Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains.
Tate-Ostroff B; Majocha RE; Marotta CA
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):745-9. PubMed ID: 2563169
[TBL] [Abstract][Full Text] [Related]
18. Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease.
Armstrong RA
Dementia; 1995; 6(3):121-5. PubMed ID: 7620523
[TBL] [Abstract][Full Text] [Related]
19. Deposition of Alzheimer's disease amyloid (A4) protein in the cerebral cortex in Parkinson's disease.
Mastaglia FL; Masters CL; Beyreuther K; Kakulas BA
Prog Clin Biol Res; 1989; 317():475-84. PubMed ID: 2690109
[TBL] [Abstract][Full Text] [Related]
20. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
Coria F; Castaño EM; Frangione B
Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
